An Open-label study to access pharmacokinetics of Finerenone and Drug-Drug interaction with Verapamil in Healthy male subjects
Latest Information Update: 29 May 2018
Price :
$35 *
At a glance
- Drugs Finerenone (Primary) ; Verapamil
- Indications Chronic heart failure; Diabetic nephropathies; Renal failure
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Bayer
- 29 May 2018 New trial record
- 19 May 2018 Results assessing the absolute bioavailability and pharmacokinetics of Finerenone in four crossover studies in healthy male volunteers, published in the European Journal of Drug Metabolism and Pharmacokinetics